Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic AI-based design of cell-specific small molecule cytotoxics.

Communications chemistry·2026
Same author

Experimental assessment of AI-based interactome mapping.

Nature communications·2026
Same author

Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation.

Science advances·2026
Same author

The modifiers that cause changes in gene essentiality.

Cell systems·2026
Same author

Effector-host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation.

Nature microbiology·2026
Same author

Inhibitors supercharge kinase turnover through native proteolytic circuits.

Nature·2025

Related Experiment Video

Updated: Jul 7, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Towards a molecular characterisation of pathological pathways.

Roland A Pache1, Andreas Zanzoni, Jordi Naval

  • 1Institute for Research in Biomedicine and Barcelona Supercomputing Center, c/Josep Samitier 1-5, 08028 Barcelona, Spain.

FEBS Letters
|February 20, 2008
PubMed
Summary

Drug discovery often fails due to reductionism. A systems pathology approach, integrating computational and experimental methods, enhances understanding of disease mechanisms for better drug development.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: Jul 7, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

  • Biomedical Sciences
  • Computational Biology
  • Pharmacology

Background:

  • Conceptual reductionism in drug discovery leads to late-stage failures.
  • Incomplete understanding of patho-physiological pathways hinders drug efficacy.
  • Need for holistic understanding of molecular mechanisms in complex diseases.

Purpose of the Study:

  • To review strategies combining computational and experimental techniques in drug discovery.
  • To propose a systems pathology approach for improved disease comprehension.
  • To enhance the success rate of drug candidates by considering biological context.

Main Methods:

  • Review of integrated computational and experimental strategies.
  • Analysis of molecular mechanisms in complex cellular processes.
  • Application of systems pathology principles to drug discovery.

Main Results:

  • Identified limitations of reductionist approaches in drug discovery.
  • Highlighted the importance of understanding molecular mechanisms in biological context.
  • Demonstrated the potential of systems pathology for better disease understanding.

Conclusions:

  • A systems pathology approach is crucial for advancing drug discovery.
  • Integrating diverse techniques improves comprehension of disease at the molecular level.
  • This approach promises to reduce late-stage drug candidate failures and improve therapeutic outcomes.